Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00319800
Status:
UNKNOWN
Last Update Posted:
2008-03-12
First Post:
2006-04-28
Brief Title:
Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC
Sponsor:
Gachon University Gil Medical Center
Organization:
Gachon University Gil Medical Center
Organization Data
Organization:
Gachon University Gil Medical Center
Class:
OTHER
Study ID:
GMO-LU-62
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gachon University Gil Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None